Aurobindo Pharma Ltd.’s first-quarter profit rose, in-line with analysts’ estimates.The Hyderabad-based bulk and generic drug maker’s net profit rose 10% year-on-year to Rs 571 crore in the quarter ended June, according to an exchange filing. That compares with the Rs 557-crore consensus estimate of analysts tracked by Bloomberg.Sequentially, it rose 13%.
This article was written byFollowFred Piard, PhD. is a quantitative analyst and IT professional with over 30 years of experience...
Last week Microsoft Israel, the local marketing and sales office of the US software giant, announced the departure of...
Mohit Malhotra, Global CEO, Dabur India Dabur India posted a consolidated net profit of ₹362 crore in the March quarter,...
Quick Read Jim Cramer said no to Applied Digital (APLD) despite its $7.5 billion CoreWeave contract, arguing the company is...
Kevin Warsh, U.S. President Donald Trump's pick to lead the Federal Reserve, cleared a key procedural hurdle on Wednesday, opening...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
